Hydromorphone Hydrochloride Tablet, Extended Release
NDC Package 72865-170-01
Package Information
Hydromorphone Hydrochloride tablets is hydromorphone hydrochloride extended-release tablets are indicated for the management of severe and persistent pain that requires an extended treatment period with a daily opioid analgesic and for which alternative treatment options are inadequate.Patients considered opioid tolerant are those who are receiving, for one week or longer, at least 60 mg oral morphine per day, 25 mcg transdermal fentanyl per hour, 30 mg oral oxycodone per day, 8 mg oral hydromorphone per day, 25 mg oral oxymorphone per day, 60 mg oral hydrocodone per day, or an equianalgesic dose of another opioid.Limitations of UseBecause of the risks of addiction, abuse, and misuse with opioids, which can occur at any dosage or duration, and because of the greater risks of overdose and death with extended-release/long-acting opioid formulations, [see Warnings and Precautions (5.1)], reserve hydromorphone hydrochloride extended-release tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.Hydromorphone hydrochloride extended-release tablets are not indicated as an as-needed (prn) analgesic. This formulation utilizes a tablet, extended release delivery system. Marketed by Xlcare Pharmaceuticals, Inc., this product is identified by NDC 72865-170 and is authorized under FDA application ANDA212133.
Identification & Billing
- RxCUI: 1306898 - HYDROmorphone HCl 32 MG 24HR Extended Release Oral Tablet
- RxCUI: 1306898 - 24 HR hydromorphone hydrochloride 32 MG Extended Release Oral Tablet
- RxCUI: 1306898 - hydromorphone hydrochloride 32 MG 24 HR Extended Release Oral Tablet
- RxCUI: 902729 - HYDROmorphone HCl 12 MG 24HR Extended Release Oral Tablet
- RxCUI: 902729 - 24 HR hydromorphone hydrochloride 12 MG Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72865 - Xlcare Pharmaceuticals, Inc.
- 72865-170 - Hydromorphone Hydrochloride
- 72865-170-01 - 100 TABLET, EXTENDED RELEASE in 1 BOTTLE
- 72865-170 - Hydromorphone Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72865-170-01 identifies a specific commercial package of 100 tablet, extended release in 1 bottle of Hydromorphone Hydrochloride, a human prescription drug labeled by Xlcare Pharmaceuticals, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This tablet, extended release is formulated for oral use and contains hydromorphone hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Xlcare Pharmaceuticals, Inc. on September 24, 2020. The current certification is valid through December 31, 2027.
How is this Xlcare Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72865017001. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.